How much revenue did Singapore Medical Group generate this year?
Singapore Medical Group has achieved a revenue of 141.35 M SGD this year.
Singapore Medical Group Revenue 2025
Singapore Medical Group Revenue
141.35 M SGD
Ticker
5OT.SI
ISIN
SG1Y37945678
In 2025, Singapore Medical Group's sales reached 141.35 M SGD, a 6.96% difference from the 132.15 M SGD sales recorded in the previous year.
The Singapore Medical Group Revenue history
| YEAR | REVENUE (undefined SGD) | GROSS MARGIN (%) |
|---|---|---|
| 2025e | 141.35 | 31,31 |
| 2024e | 132.15 | 33,49 |
| 2023e | 117.16 | 37,78 |
| 2022e | 112.11 | 39,48 |
| 2021 | 100.84 | 43,89 |
| 2020 | 87.34 | 43,55 |
| 2019 | 94.67 | 45,67 |
| 2018 | 85.07 | 44,43 |
| 2017 | 68 | 42,61 |
| 2016 | 41.58 | 35,85 |
| 2015 | 30.97 | 31,21 |
| 2014 | 26.51 | 33,22 |
| 2013 | 22.89 | 29,97 |
| 2012 | 30.72 | 37,11 |
| 2011 | 31.32 | 41,19 |
| 2010 | 34.85 | 55,90 |
| 2009 | 31.99 | 56,83 |
| 2008 | 30.12 | 59,50 |
| 2007 | 24.65 | 64,83 |
| 2006 | 4.28 | 82,71 |
Singapore Medical Group Revenue, EBIT, Net Income SG1Y37945678 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Singapore Medical Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Singapore Medical Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Singapore Medical Group’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Singapore Medical Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Singapore Medical Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Singapore Medical Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Singapore Medical Group’s growth potential.
Singapore Medical Group Revenue, EBIT and net profit per share
| Date | Singapore Medical Group Revenue | Singapore Medical Group EBIT | Singapore Medical Group Net Income |
|---|---|---|---|
| 2025e | 141.35 M undefined | 25.15 M undefined | 35.68 M undefined |
| 2024e | 132.15 M undefined | 22.71 M undefined | 24.23 M undefined |
| 2023e | 117.16 M undefined | 18.89 M undefined | 16.62 M undefined |
| 2022e | 112.11 M undefined | 17.47 M undefined | 15.64 M undefined |
| 2021 | 100.84 M undefined | 18.78 M undefined | 15.61 M undefined |
| 2020 | 87.34 M undefined | 14.15 M undefined | 8.73 M undefined |
| 2019 | 94.67 M undefined | 17.25 M undefined | 13.66 M undefined |
| 2018 | 85.07 M undefined | 15.14 M undefined | 12.93 M undefined |
| 2017 | 68 M undefined | 10.44 M undefined | 8.5 M undefined |
| 2016 | 41.58 M undefined | 2.77 M undefined | 2.42 M undefined |
| 2015 | 30.97 M undefined | 361,000 undefined | -148,000 undefined |
| 2014 | 26.51 M undefined | -205,000 undefined | 79,000 undefined |
| 2013 | 22.89 M undefined | -3.83 M undefined | -6.44 M undefined |
| 2012 | 30.72 M undefined | -550,000 undefined | -1.57 M undefined |
| 2011 | 31.32 M undefined | -1.28 M undefined | -1.13 M undefined |
| 2010 | 34.85 M undefined | 3.3 M undefined | 2.34 M undefined |
| 2009 | 31.99 M undefined | 2.26 M undefined | 1.55 M undefined |
| 2008 | 30.12 M undefined | 6.23 M undefined | 5 M undefined |
| 2007 | 24.65 M undefined | 9.91 M undefined | 8.15 M undefined |
| 2006 | 4.28 M undefined | 1.63 M undefined | 1.29 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2006 | 4.28 M SGD | 1.63 M SGD | 1.29 M SGD |
| 2007 | 24.65 M SGD | 9.91 M SGD | 8.15 M SGD |
| 2008 | 30.12 M SGD | 6.23 M SGD | 5 M SGD |
| 2009 | 31.99 M SGD | 2.26 M SGD | 1.55 M SGD |
| 2010 | 34.85 M SGD | 3.3 M SGD | 2.34 M SGD |
| 2011 | 31.32 M SGD | -1.28 M SGD | -1.13 M SGD |
| 2012 | 30.72 M SGD | -550,000 SGD | -1.57 M SGD |
| 2013 | 22.89 M SGD | -3.83 M SGD | -6.44 M SGD |
| 2014 | 26.51 M SGD | -205,000 SGD | 79,000 SGD |
| 2015 | 30.97 M SGD | 361,000 SGD | -148,000 SGD |
| 2016 | 41.58 M SGD | 2.77 M SGD | 2.42 M SGD |
| 2017 | 68 M SGD | 10.44 M SGD | 8.5 M SGD |
| 2018 | 85.07 M SGD | 15.14 M SGD | 12.93 M SGD |
| 2019 | 94.67 M SGD | 17.25 M SGD | 13.66 M SGD |
| 2020 | 87.34 M SGD | 14.15 M SGD | 8.73 M SGD |
| 2021 | 100.84 M SGD | 18.78 M SGD | 15.61 M SGD |
| 2022e | 112.11 M SGD | 17.47 M SGD | 15.64 M SGD |
| 2023e | 117.16 M SGD | 18.89 M SGD | 16.62 M SGD |
| 2024e | 132.15 M SGD | 22.71 M SGD | 24.23 M SGD |
| 2025e | 141.35 M SGD | 25.15 M SGD | 35.68 M SGD |
Singapore Medical Group stock margins SG1Y37945678 ·
The Singapore Medical Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Singapore Medical Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Singapore Medical Group.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Singapore Medical Group's sales revenue. A higher gross margin percentage indicates that the Singapore Medical Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Singapore Medical Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Singapore Medical Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Singapore Medical Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Singapore Medical Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Singapore Medical Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Singapore Medical Group Margin History
| Singapore Medical Group Gross margin | Singapore Medical Group Profit margin | Singapore Medical Group EBIT margin | Singapore Medical Group Profit margin |
|---|---|---|---|
| 2025e | 43.89 % | 17.79 % | 25.24 % |
| 2024e | 43.89 % | 17.19 % | 18.34 % |
| 2023e | 43.89 % | 16.12 % | 14.19 % |
| 2022e | 43.89 % | 15.59 % | 13.95 % |
| 2021 | 43.89 % | 18.62 % | 15.48 % |
| 2020 | 43.55 % | 16.2 % | 10 % |
| 2019 | 45.67 % | 18.22 % | 14.43 % |
| 2018 | 44.43 % | 17.8 % | 15.2 % |
| 2017 | 42.61 % | 15.35 % | 12.5 % |
| 2016 | 35.85 % | 6.66 % | 5.83 % |
| 2015 | 31.21 % | 1.17 % | -0.48 % |
| 2014 | 33.22 % | -0.77 % | 0.3 % |
| 2013 | 29.97 % | -16.73 % | -28.13 % |
| 2012 | 37.11 % | -1.79 % | -5.11 % |
| 2011 | 41.19 % | -4.09 % | -3.61 % |
| 2010 | 55.9 % | 9.47 % | 6.71 % |
| 2009 | 56.83 % | 7.06 % | 4.85 % |
| 2008 | 59.5 % | 20.68 % | 16.6 % |
| 2007 | 64.83 % | 40.2 % | 33.06 % |
| 2006 | 82.71 % | 38.08 % | 30.14 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2006 | 82.71 % | 38.08 % | 30.14 % |
| 2007 | 64.83 % | 40.2 % | 33.06 % |
| 2008 | 59.5 % | 20.68 % | 16.6 % |
| 2009 | 56.83 % | 7.06 % | 4.85 % |
| 2010 | 55.9 % | 9.47 % | 6.71 % |
| 2011 | 41.19 % | -4.09 % | -3.61 % |
| 2012 | 37.11 % | -1.79 % | -5.11 % |
| 2013 | 29.97 % | -16.73 % | -28.13 % |
| 2014 | 33.22 % | -0.77 % | 0.3 % |
| 2015 | 31.21 % | 1.17 % | -0.48 % |
| 2016 | 35.85 % | 6.66 % | 5.83 % |
| 2017 | 42.61 % | 15.35 % | 12.5 % |
| 2018 | 44.43 % | 17.8 % | 15.2 % |
| 2019 | 45.67 % | 18.22 % | 14.43 % |
| 2020 | 43.55 % | 16.2 % | 10 % |
| 2021 | 43.89 % | 18.62 % | 15.48 % |
| 2022e | 43.89 % | 15.59 % | 13.95 % |
| 2023e | 43.89 % | 16.12 % | 14.19 % |
| 2024e | 43.89 % | 17.19 % | 18.34 % |
| 2025e | 43.89 % | 17.79 % | 25.24 % |
Singapore Medical Group Aktienanalyse
What does Singapore Medical Group do?
The Singapore Medical Group Ltd is a leading company in the healthcare industry based in Singapore and with branches in various cities in Asia. The company's history dates back to 2005 when it was established as a small medical institute. Over the years, it has become one of the largest and most successful providers of healthcare services in Asia. SMG's business model is based on the vision of providing comprehensive healthcare services to all patients in one place. This includes general medicine as well as specialties such as cardiology, gastroenterology, oncology, orthopedics, and gynecology. Additionally, SMG also offers services such as diagnostics, imaging, rehabilitation, and wellness. SMG strives to provide its customers with the highest level of comfort and satisfaction. SMG has various divisions, including the Women and Children's clinic, the oncology department, the cardiology department, and the orthopedic department. In the Women and Children's clinic, the company offers a wide range of services such as prenatal care, obstetrics, gynecology, and pediatric care. The oncology department provides state-of-the-art diagnostic and treatment services for cancer patients. The cardiology department offers diagnostic and treatment services for heart diseases, while the orthopedic department offers diagnostic and treatment services for musculoskeletal disorders. SMG also offers a wide range of products, including medical devices, pharmaceuticals, and supplements. The company has many partnerships with leading manufacturers of medical devices and pharmaceuticals worldwide to provide its customers with the best products and services. Over the years, SMG has received numerous awards for its outstanding performance in the healthcare industry. Some of these awards include the Healthcare Asia Awards, the Global Health & Travel Awards, and the Singapore Health Quality Service Awards. The recognition for its work demonstrates SMG's commitment and success in the well-being of its patients. Overall, the history and success of SMG show that the company is a leading provider of healthcare services in Asia. With a comprehensive range of services and products focusing on the needs of patients, SMG has achieved a strong position in the market. SMG is committed to providing its customers with the highest level of comfort and satisfaction and is expected to continue growing and evolving in the years to come. Singapore Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Singapore Medical Group's Sales Figures
The sales figures of Singapore Medical Group originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Singapore Medical Group’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Singapore Medical Group's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Singapore Medical Group’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Singapore Medical Group stock
How much was the turnover of the company Singapore Medical Group compared to the previous year?
The revenue of Singapore Medical Group has increased by 6.96% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Singapore Medical Group?
The revenue of Singapore Medical Group is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Singapore Medical Group measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Singapore Medical Group so important for investors?
The revenue of Singapore Medical Group is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Singapore Medical Group pay?
Over the past 12 months, Singapore Medical Group paid a dividend of 0 SGD . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Singapore Medical Group is expected to pay a dividend of 0.01 SGD.
What is the dividend yield of Singapore Medical Group?
The current dividend yield of Singapore Medical Group is 1.01 %.
When does Singapore Medical Group pay dividends?
Singapore Medical Group pays a quarterly dividend. This is distributed in the months of May, July, June, June.
How secure is the dividend of Singapore Medical Group?
Singapore Medical Group paid dividends every year for the past 6 years.
What is the dividend of Singapore Medical Group?
For the upcoming 12 months, dividends amounting to 0.01 SGD are expected. This corresponds to a dividend yield of 1.98 %.
In which sector is Singapore Medical Group located?
Singapore Medical Group is assigned to the 'Health' sector.
Wann musste ich die Aktien von Singapore Medical Group kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Singapore Medical Group from 5/13/2022 amounting to 0.009 SGD, you needed to have the stock in your portfolio before the ex-date on 5/4/2022.
When did Singapore Medical Group pay the last dividend?
The last dividend was paid out on 5/13/2022.
What was the dividend of Singapore Medical Group in the year 2024?
In the year 2024, Singapore Medical Group distributed 0.006 SGD as dividends.
In which currency does Singapore Medical Group pay out the dividend?
The dividends of Singapore Medical Group are distributed in SGD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Singapore Medical Group
Our stock analysis for Singapore Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Singapore Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Singapore Medical Group Revenue
- Singapore Medical Group Net Income
- Singapore Medical Group P/E
- Singapore Medical Group P/S
- Singapore Medical Group EBIT
- Singapore Medical Group Dividend
- Singapore Medical Group Stocks
- Singapore Medical Group Market capitalization
- Singapore Medical Group Debt
- Singapore Medical Group Liabilities
- Singapore Medical Group Equity
- Singapore Medical Group AAQS
- Singapore Medical Group Employees
- Singapore Medical Group ROE
- Singapore Medical Group ROA
- Singapore Medical Group ROCE
